HIGHLIGHTS
- who: The hexosamine pathway and colleagues from the Centre de Recherche en Cancu00e9rologie de Lyon, INSERM, Centre National de la Recherche Scientifique (CNRS), Centre Lu00e9on Bu00e9rard, Universitu00e9 de Lyon, Universitu00e9 Claude Bernard Lyon, Lyon, France Institute for Regenerative Medecine and Biotherapy (IRBM), Universitu00e9 de Montpellier, INSERM, Montpellier, France Inserm, Centre de Lutte Contre le Cancer Eugeu0300ne Marquis, Universitu00e9 de Rennes, Rennes, France Universitu00e9 Grenoble Alpes, INSERM, Commissariat au0300 l`Energie Atomique (CEA), Unite Mixte de Recherche (UMR) BioSantu00e9, CNRS, CEA, FR2048, Grenoble, France U Hospices Civils of Lyon, Biochemistry and Pharmaco-toxicology Laboratory, Lyon Sud Hospital, Lyon . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.